— Henry I. Miller, a physician and molecular biologist, is the Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford University’s Hoover Institution. He was the founding director of the FDA’s Office of Biotechnology.
High-level officials of the United Nations are not known for their perspicacity, competence, or scientific acumen, but the head of the World Health Organization (WHO), Margaret Chan, is a particular embarrassment. With so much attention focused on the Ebola-virus outbreak in Africa, her exaggerations and petty scolding have made her a high-profile liability.
In a speech at a regional conference in Benin last month, she warned that the Ebola outbreak “is the most severe acute public-health emergency seen in modern times” and bashed pharmaceutical companies for not developing Ebola vaccines — products that could not possibly be profitable. “A profit-driven industry does not invest in products for markets that cannot pay,” she said — a truism if there ever was one. “WHO has been trying to make this issue visible for ages. Now people can see for themselves.”
Perhaps Dr. Chan is unaware of the U.N.’s own data on the infectious and other public-health scourges that afflict the developing world, Africa in particular.
Let’s consider first how Ebola stacks up against other public-health emergencies in developing countries. As the United Nations’ own data make clear, infectious diseases, many of them preventable and treatable, remain the scourge of poorer populations. In 2008, about 250 million cases of malaria caused almost a million deaths, mostly of children younger than five. In virtually all poor, malaria-endemic countries, there is inadequate access to antimalarial medicines (especially artemisinin-based combination therapy).
The incidence of malaria could be reduced dramatically by the judicious application of the mosquito-killing chemical DDT, but the U.N. and national regulators have curtailed its availability, owing to misguided notions about its toxicity (and no small measure of political correctness). Hundreds of millions suffer from other neglected tropical diseases, including lymphatic filariasis and cholera.
Although new HIV infections worldwide declined slightly during the past decade, 2.7 million people contracted the virus in 2008, and there were 2 million HIV/AIDS-related deaths. By the end of that year, more than 4 million people in low- and middle-income countries were receiving anti-retroviral therapy, but more than 5 million who were HIV-positive remained untreated. The number of new cases of tuberculosis worldwide is increasing, and the growing emergence of multi-drug-resistant strains of the bacteria is especially worrisome.